C

Curis
D

CRIS

3.26000
USD
-0.16
(-4.68%)
مغلق
حجم التداول
2,939
الربح لكل سهم
-4
العائد الربحي
-
P/E
-0
حجم السوق
27,602,280
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    ALNY
    ALNY
    1.73
    (0.65%)
    266.69 USD
    B
    BLUE
    -0.31000
    (-3.79%)
    7.86000 USD
    B
    BNTC
    0.010
    (0.09%)
    10.690 USD
    C
    CRSP
    2.740
    (6.61%)
    44.200 USD
    E
    EDIT
    0.15000
    (12.50%)
    1.35000 USD
    GILD
    GILD
    0.070
    (0.08%)
    93.020 USD
    N
    NTLA
    1.040
    (10.45%)
    10.990 USD
    REGN
    REGN
    -7.47
    (-1.09%)
    679.85 USD
    S
    SGMO
    0.03500
    (3.13%)
    1.15500 USD
    VRTX
    VRTX
    0.08
    (0.02%)
    428.09 USD
    المزيد
الأخبار
المقالات

العنوان: Curis

القطاع: Healthcare
الصناعة: Biotechnology
Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advancedsolid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.